ExodusPoint Capital Management, LP - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 67 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$120,000
+93.5%
14,548
+31.7%
0.00%
+100.0%
Q1 2022$62,000
+17.0%
11,044
-2.0%
0.00%0.0%
Q4 2021$53,000
-89.3%
11,264
-85.0%
0.00%
-80.0%
Q2 2021$494,000
+236.1%
75,015
+273.7%
0.01%
+150.0%
Q1 2021$147,000
-24.6%
20,072
-47.1%
0.00%
-60.0%
Q2 2020$195,00037,9240.01%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,952,958$23,481,0000.99%
Cormorant Asset Management, LP 1,000,000$5,940,0000.23%
WealthTrust Axiom LLC 22,347$132,0000.06%
SECTORAL ASSET MANAGEMENT INC 100,000$594,0000.05%
Virtu Financial LLC 24,577$146,0000.02%
PDT Partners, LLC 61,839$367,0000.02%
SABBY MANAGEMENT, LLC 26,039$155,0000.02%
MGO ONE SEVEN LLC 10,000$59,0000.01%
WINTON GROUP Ltd 45,208$269,0000.01%
Ancora Advisors LLC 36,350$216,0000.01%
View complete list of AVEO PHARMACEUTICALS INC shareholders